Home LiteratureArticle Details
PMID: 1906576 Published · ppublish English Comparative Study Journal Article

Identification of amino acid residues required for Ras p21 target activation.

Molecular and cellular biology ·Vol. 11 ·No. 8 ·1991-08-00 ·Pages 3997-4004

Marshall MS, Davis LJ, Keys RD, Mosser SD, Hill WS, Scolnick EM, Gibbs JB

Abstract

The Krev-1 gene has been shown to suppress ras-mediated transformation in vitro. Both ras and Krev-1 proteins have identical effector domains (ras residues 32 to 40), which are required for biological activity and for the interaction of Ras p21 with Ras GTPase-activating protein (GAP). In this study, five amino acid residues flanking the ras effector domain, which are not conserved with the Krev-1 protein, were shown to be required for normal protein-protein interactions and biological activity. The substitution of Krev-1 p21 residues 26, 27, 30, 31, and 45 with the corresponding amino acid residues from Ras p21 resulted in a Krev-1 protein which had ras function in both mammalian and yeast biological assays. Replacement of these residues in Ras p21 with the corresponding Krev-1 p21 amino acids resulted in ras proteins which were impaired biologically or reduced in their affinity for in vitro GAP binding. Evaluation of these mutant ras proteins have implications for Ras p21-GAP interactions in vivo.

MeSH Terms
Amino Acid Sequence Animals Cell Line DNA Replication DNA, Recombinant/metabolism GTP-Binding Proteins/genetics Genes, ras Mice Molecular Sequence Data Mutagenesis, Site-Directed Oncogene Protein p21(ras)/genetics Proto-Oncogene Proteins/genetics Proto-Oncogenes Restriction Mapping Sequence Homology, Nucleic Acid Suppression, Genetic Thymidine/metabolism Transfection rap GTP-Binding Proteins
Chemicals
DNA, Recombinant Proto-Oncogene Proteins GTP-Binding Proteins Oncogene Protein p21(ras) rap GTP-Binding Proteins Thymidine
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Marshall M S
Department of Cancer Research, Merck Sharp and Dohme Research Laboratories, West Point, Pennsylvania 19486.
Davis L J
Keys R D
Mosser S D
Hill W S
Scolnick E M
Gibbs J B
References (44)
44 references, click to expand
  1. Modulation of guanine nucleotides bound to Ras in NIH3T3 cells by oncogenes, growth factors, and the GTPase activating protein (GAP).
    J Biol Chem. 1990 Nov 25;265(33):20437-42 PMID: 2122974
  2. Tissue and subcellular distributions of the smg-21/rap1/Krev-1 proteins which are partly distinct from those of c-ras p21s.
    Mol Cell Biol. 1990 Jun;10(6):2645-52 PMID: 2111441
  3. The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae.
    Cell. 1990 Nov 16;63(4):835-41 PMID: 2121369
  4. The COOH-terminal domain of the Rap1A (Krev-1) protein is isoprenylated and supports transformation by an H-Ras:Rap1A chimeric protein.
    Mol Cell Biol. 1991 Mar;11(3):1523-30 PMID: 1899909
  5. Preferential inhibition of the oncogenic form of RasH by mutations in the GAP binding/"effector" domain.
    Cell. 1991 Feb 8;64(3):625-33 PMID: 1899358
  6. A C-terminal domain of GAP is sufficient to stimulate ras p21 GTPase activity.
    EMBO J. 1989 Apr;8(4):1105-10 PMID: 2545441
  7. The ras oncogene--an important regulatory element in lower eucaryotic organisms.
    Microbiol Rev. 1989 Jun;53(2):171-85 PMID: 2547147
  8. All ras proteins are polyisoprenylated but only some are palmitoylated.
    Cell. 1989 Jun 30;57(7):1167-77 PMID: 2661017
  9. Structure of the guanine-nucleotide-binding domain of the Ha-ras oncogene product p21 in the triphosphate conformation.
    Nature. 1989 Sep 21;341(6239):209-14 PMID: 2476675
  10. Structure/function studies of the ras protein.
    Cold Spring Harb Symp Quant Biol. 1988;53 Pt 2:863-9 PMID: 3151189
  11. PDGF induction of tyrosine phosphorylation of GTPase activating protein.
    Nature. 1989 Dec 7;342(6250):711-4 PMID: 2480526
  12. A novel small molecular weight GTP-binding protein with the same putative effector domain as the ras proteins in bovine brain membranes. Purification, determination of primary structure, and characterization.
    J Biol Chem. 1988 Dec 15;263(35):18965-71 PMID: 3143720
  13. Ras interaction with the GTPase-activating protein (GAP).
    Proteins. 1989;6(3):306-15 PMID: 2516318
  14. Three-dimensional structure of an oncogene protein: catalytic domain of human c-H-ras p21.
    Science. 1988 Feb 19;239(4842):888-93 PMID: 2448879
  15. Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain.
    Science. 1988 Apr 22;240(4851):518-21 PMID: 2833817
  16. The cytoplasmic protein GAP is implicated as the target for regulation by the ras gene product.
    Nature. 1988 Apr 7;332(6164):548-51 PMID: 2833702
  17. Transformation and stimulation of DNA synthesis in NIH-3T3 cells are a titratable function of normal p21N-ras expression.
    EMBO J. 1986 Oct;5(10):2617-21 PMID: 3023052
  18. Mutational analysis of a ras catalytic domain.
    Mol Cell Biol. 1986 Jul;6(7):2646-54 PMID: 3023943
  19. Human cDNAs rap1 and rap2 homologous to the Drosophila gene Dras3 encode proteins closely related to ras in the 'effector' region.
    Oncogene. 1988 Aug;3(2):201-4 PMID: 3045729
  20. Cloning of bovine GAP and its interaction with oncogenic ras p21.
    Nature. 1988 Sep 1;335(6185):90-3 PMID: 2842690
  21. Purification of ras GTPase activating protein from bovine brain.
    Proc Natl Acad Sci U S A. 1988 Jul;85(14):5026-30 PMID: 3293047
  22. Yeast and mammalian ras proteins have conserved biochemical properties.
    Nature. 1985 Feb 21-27;313(6004):700-3 PMID: 3919305
  23. Identification of effector residues and a neutralizing epitope of Ha-ras-encoded p21.
    Proc Natl Acad Sci U S A. 1986 Jul;83(13):4725-9 PMID: 2425352
  24. Yeast mutants temperature-sensitive for growth after random mutagenesis of the chromosomal RAS2 gene and deletion of the RAS1 gene.
    EMBO J. 1988 Nov;7(11):3375-83 PMID: 3145192
  25. Guanine nucleotide activation of, and competition between, RAS proteins from Saccharomyces cerevisiae.
    Mol Cell Biol. 1987 Jun;7(6):2128-33 PMID: 3299060
  26. Suppression of defective RAS1 and RAS2 functions in yeast by an adenylate cyclase activated by a single amino acid change.
    EMBO J. 1986 Dec 20;5(13):3657-63 PMID: 3549283
  27. An adenylate cyclase from Saccharomyces cerevisiae that is stimulated by RAS proteins with effector mutations.
    Mol Cell Biol. 1988 Jan;8(1):52-61 PMID: 3275878
  28. Differential activation of yeast adenylate cyclase by wild-type and mutant RAS proteins.
    Cell. 1985 Jul;41(3):763-9 PMID: 3891097
  29. Suppressors of the ras2 mutation of Saccharomyces cerevisiae.
    Genetics. 1986 Jun;113(2):247-64 PMID: 3013722
  30. A ras-related gene with transformation suppressor activity.
    Cell. 1989 Jan 13;56(1):77-84 PMID: 2642744
  31. Functional homology of mammalian and yeast RAS genes.
    Cell. 1985 Jan;40(1):19-26 PMID: 2981628
  32. Overproduction of protein kinase C causes disordered growth control in rat fibroblasts.
    Cell. 1988 Feb 12;52(3):343-54 PMID: 3345563
  33. Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules.
    Proc Natl Acad Sci U S A. 1984 Sep;81(18):5704-8 PMID: 6148751
  34. ras genes.
    Annu Rev Biochem. 1987;56:779-827 PMID: 3304147
  35. Carbon source regulation of RAS1 expression in Saccharomyces cerevisiae and the phenotypes of ras2- cells.
    Proc Natl Acad Sci U S A. 1986 Jun;83(12):4152-6 PMID: 3520568
  36. Stimulation of p21ras upon T-cell activation.
    Nature. 1990 Aug 23;346(6286):719-23 PMID: 2201921
  37. Three-dimensional structures of H-ras p21 mutants: molecular basis for their inability to function as signal switch molecules.
    Cell. 1990 Aug 10;62(3):539-48 PMID: 2199064
  38. Platelet-derived growth factor stimulates formation of active p21ras.GTP complex in Swiss mouse 3T3 cells.
    Proc Natl Acad Sci U S A. 1990 Aug;87(15):5993-7 PMID: 2198577
  39. Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases.
    Nature. 1990 Jan 25;343(6256):377-81 PMID: 1689011
  40. Inhibition of the ras p21 GTPase-activating protein-stimulated GTPase activity of c-Ha-ras p21 by smg p21 having the same putative effector domain as ras p21s.
    J Biol Chem. 1990 May 5;265(13):7104-7 PMID: 2158984
  41. Inhibition of GTPase activating protein stimulation of Ras-p21 GTPase by the Krev-1 gene product.
    Science. 1990 Jul 13;249(4965):169-71 PMID: 2164710
  42. Identification of small clusters of divergent amino acids that mediate the opposing effects of ras and Krev-1.
    Science. 1990 Jul 13;249(4965):162-5 PMID: 2115210
  43. Genetic analysis of the Kirsten-ras-revertant 1 gene: potentiation of its tumor suppressor activity by specific point mutations.
    Proc Natl Acad Sci U S A. 1990 Jun;87(11):4284-8 PMID: 2112251
  44. Posttranslationally processed structure of the human platelet protein smg p21B: evidence for geranylgeranylation and carboxyl methylation of the C-terminal cysteine.
    Proc Natl Acad Sci U S A. 1990 Nov;87(22):8960-4 PMID: 2123345
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
1991-08-00
Pages
3997-4004
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC361200
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com